Garratt, C., Packer, M., Colucci, W., Fisher, L., Massie, B., Teerlink, J., & Young, J. (2004). Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: Results with levosimendan in the REVIVE 1 study. BioMed Central.
Citação norma ChicagoGarratt, C., M. Packer, W. Colucci, L. Fisher, B. Massie, J. Teerlink, and J. Young. Development of a Comprehensive New Endpoint for the Evaluation of New Treatments for Acute Decompensated Heart Failure: Results With Levosimendan in the REVIVE 1 Study. BioMed Central, 2004.
MLA引文Garratt, C., et al. Development of a Comprehensive New Endpoint for the Evaluation of New Treatments for Acute Decompensated Heart Failure: Results With Levosimendan in the REVIVE 1 Study. BioMed Central, 2004.